CrossRef Text and Data Mining

Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.

Entecavir versus tenofovir in patients with chronic hepatitis B: Enemies or partners in the prevention of hepatocellular carcinoma

Sung Won Lee, Jonggi Choi, Seung Up Kim, Young-Suk Lim

Clin Mol Hepatol. 2021;27(3):402-412. Published online 2021 June 23 DOI: https://doi.org/10.3350/cmh.2021.0179

Entecavir versus tenofovir in patients with chronic hepatitis B: Enemies or partners in the prevention of hepatocellular carcinoma

Sung Won Lee, Jonggi Choi, Seung Up Kim, Young-Suk Lim

Clinical and Molecular Hepatology. 2021;27(3):402-412

Link1

Link2 Link3

Entecavir versus Tenofovir for the Prevention of Hepatocellular Carcinoma in Treatment-naïve Chronic Hepatitis B Patients in Korea

HeeKyoung Choi, Gi Hyeon Seo

Journal of Korean Medical Science. 2021;36(14):

Link1 Link2 Link3

Comparison of Tenofovir and Entecavir in the Prevention of Hepatocellular Carcinoma Occurrence in Patients with Chronic Hepatitis B

Antonio Facciorusso, Ivan Cincione, Rodolfo Sacco

Liver Cancer. 2021;10(3):285-286

Link1 Link2

Tenofovir versus entecavir for tertiary prevention of hepatocellular carcinoma in chronic hepatitis B infection after curative therapy: A systematic review and meta‐analysis

Suprabhat Giri, Dhiraj Agrawal, Shivaraj Afzalpurkar, Amrit Gopan, Sumaswi Angadi, Sridhar Sundaram

Journal of Viral Hepatitis. 2022;30(2):108-115

Link1 Link2 Link3

Letter: is tenofovir superior to entecavir for hepatocellular carcinoma prevention in chronic hepatitis B?

Bao-Hong Yuan, Yan-Kun Zhu, Ru-Hong Li

Alimentary Pharmacology & Therapeutics. 2019;51(2):314-315

Link1 Link2

Is Tenofovir Associated with a Lower Risk of Hepatocellular Carcinoma in Patients with Chronic Hepatitis B Compared With Entecavir?

Faisal Kamal, Muhammad Ali Khan

Gastroenterology. 2020;158(8):2311-2312

Link1 Link2

Letter: is tenofovir superior to entecavir for hepatocellular carcinoma prevention in chronic hepatitis B? Authors’ reply

Terry C.-F. Yip, Grace L.-H. Wong

Alimentary Pharmacology & Therapeutics. 2019;51(2):315-316

Link1 Link2

Risk of Hepatocellular Carcinoma With Tenofovir vs Entecavir in Patients With Chronic Hepatitis B

Han Ah Lee, Yeon Seok Seo, Seung Up Kim

Gastroenterology. 2020;158(8):2310-2311

Link1 Link2

Risk of hepatocellular carcinoma with tenofovir versus entecavir in chronic hepatitis B – Authors' reply

Cheng-Hao Tseng, Yao-Chun Hsu, Mindie H Nguyen

The Lancet Gastroenterology & Hepatology. 2021;6(2):87-88

Link1 Link2

Tenofovir Versus Entecavir on Recurrence of Hepatitis B Virus–Related Hepatocellular Carcinoma After Surgical Resection

Jonggi Choi, Chanyoung Jo, Young‐Suk Lim

Hepatology. 2020;73(2):661-673

Link1 Link2 Link3 Link4

This metadata service is kindly provided by CrossRef from May 29, 2014. Clin Mol Hepatol has participated in CrossRef Text and Data Mining service since March 1, 2015.